
|Videos|June 19, 2018
Looking Back on the First Immune Checkpoint Inhibitor Approved in Melanoma
Author(s)Alexander M. Eggermont, MD, PhD
Alexander M. Eggermont, MD, PhD, director general of Gustave Roussy Cancer Campus Grand Paris in Villejuif, France, discusses the history of immune checkpoint inhibitors in the treatment landscape of melanoma.
Alexander M. Eggermont, MD, PhD, director general of Gustave Roussy Cancer Campus Grand Paris in Villejuif, France, discusses the history of immune checkpoint inhibitors in the treatment landscape of melanoma.



















